Company intelligence / Profile preview

Carie Boyd Pharmaceuticals

Irving, Texas, United States

Ownership: Private
Employees: ~71
Development stage: Other

Overview

Carie Boyd Pharmaceuticals is a leading US compounding pharmacy and 503B outsourcing facility, specializing in commercial supply of compounded hormones (notably implantable pellets), adjunctive hormone therapies, pain management, dermatological, weight loss, dental, hair loss, and veterinary compounded products. Their hormone pellet products have industry-leading potency precision and low noncompliance rates[1][5][6].

Therapeutic areas: EndocrinologyMen's HealthDermatologyOtherNeurologyWomen's Health
Modalities: Small moleculeHormonePeptidesProteinTabletCapsuleTopicalImplantable pelletSuspension
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Carie Boyd Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carie Boyd Pharmaceuticals.

Explore the full profile